The Effect of Virtual Exercises on Glycemic Control and Body Composition in Type 2 Diabetic Patients

The Effect of Virtual Exercises on Glycemic Control, Body Composition, Psychological Status and Quality of Life in Type 2 Diabetic Patients

This study was conducted to evaluate the effect of exercises with VR goggles in patients with type 2 diabetes.

The effect of exercise in virtual reality goggles on glycemic control, body composition, quality of life and psychological status.

Study Overview

• Status: Completed
• Conditions: Diabetes Mellitus Type 2
• Intervention / Treatment: Other: exercise with virtual reality goggles

Detailed Description

For virtual reality applications, a screen will be worn on the user's head that provides a three-dimensional visual image, thus creating a sense of space and depth. Blood glucose levels, vital signs and oxygen consumption capacity measurements will be monitored with the smart watch throughout the VR exercise application.

• Study Type: Interventional
• Enrollment (Actual): 68
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Turkey
  • İstanbul, Turkey, 340340
    • İstanbul Sabahattin Zaim Üniversitesi, Sağlık Bilimleri Fakültesi

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

Being over 18 years old able to communicate Volunteering to participate in the research

Exclusion Criteria:

Those with psychiatric problems Being unconscious

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Supportive Care
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
No Intervention: Control group; Routine maintenance will be applied
Experimental: Virtual reality glasses; Patients with type 2 diabetes were planned to exercise for 10 minutes warm-up and 10 minutes cool down and 30 minutes exercise for 50 minutes in total	Other: exercise with virtual reality goggles; Exercise and smartwatch tracking for type 2 diabetics with virtual reality glasses

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Glycemic Control Analysis	HbA1c levels of patients in the intervention and control groups will be checked	3 months
Analysis of Body Composition Values	Body analysis will be performed with a validated device. The patient will be measured before and after exercise and fat mass, lean mass, muscle mass, visceral fat ratio and basal metabolic rate will be measured by the device.	3 months
fat mass	patients will be tested for fat mass on the device	3 months
lean mass	patients will have a device to check their lean mass.	3 months
muscle mass	patients' muscle mass will be checked with the device	3 months
visceral fat content	patients will be tested for visceral fat with the device	3 months
basal metabolic rate	patients' basal metabolic rate will be monitored with the device	3 months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Depression Anxiety Stress Scale	As the score of the answers to the questions increases, the level of depression, anxiety and stress increases. A score of 5 points or more in the depression sub-dimension, 4 points or more in anxiety, and 8 points or more in stress indicates that the individual has a related problem.	3 months
SF-36 Quality of Life Scale	The scale, which includes thirty-six statements, is a multi-item scale assessing 8 health concepts (physical function, physical role, fitness/fatigue, pain, general health perception, social function, emotional role, mental health) and 2 main topics (physical dimension and mental dimension).	3 months
Satisfaction Survey	There are 11 questions to evaluate the satisfaction of the patients about VR application and to question the conditions such as headache, dizziness, eye fatigue, disorientation, vertigo, loss of skin color, nausea and vomiting that may develop due to the use of virtual reality goggles.	3 months

Collaborators and Investigators

• Sponsor: Istanbul Sabahattin Zaim University

Study record dates

Study Major Dates

• Study Start (Actual): July 28, 2023
• Primary Completion (Actual): June 1, 2024
• Study Completion (Actual): December 1, 2024

Study Registration Dates

• First Submitted: February 6, 2025
• First Submitted That Met QC Criteria: February 24, 2025
• First Posted (Actual): March 25, 2025

Study Record Updates

• Last Update Posted (Actual): March 25, 2025
• Last Update Submitted That Met QC Criteria: February 24, 2025
• Last Verified: February 1, 2025

More Information

Terms related to this study

• Keywords: diabetes, glycemic control, virtual reality, quality of life
• Additional Relevant MeSH Terms: Endocrine System Diseases; Metabolic Diseases; Glucose Metabolism Disorders; Diabetes Mellitus; Diabetes Mellitus, Type 2
• Other Study ID Numbers: 2023-07

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No